Venture firms New Enterprise Associates (NEA) and Kleiner Perkins Caufield and Perkins (KPCB) have raised $20m in a series C round for life sciences startup 3-V Biosciences.

Originally based in Zurich, Switzerland, 3-V has since relocated to Silicon Valley in 2010. The startup maintains close ties with the University of Zurich and the Swiss Federal Institute of Technology, the institutions of the firm’s founding scientific partners.

3-V was founded in 2007 with support from venture firms The Column Group (TCG)…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?